Working… Menu
Trial record 1 of 2 for:    BOSTON-3
Previous Study | Return to List | Next Study

Open-Label, Extension Trial to Demonstrate the Effectiveness and Safety of L-CsA Plus Standard of Care in the Treatment of BOS in Patients Post Single or Double Lung Transplant (BOSTON-3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04039347
Recruitment Status : Enrolling by invitation
First Posted : July 31, 2019
Last Update Posted : March 29, 2021
Information provided by (Responsible Party):
Zambon SpA

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : March 2024
Estimated Study Completion Date : April 2024